Accès gratuit
Numéro
Med Sci (Paris)
Volume 19, Numéro 12, Décembre 2003
Page(s) 1226 - 1232
Section M/S revues
DOI https://doi.org/10.1051/medsci/200319121226
Publié en ligne 15 décembre 2003
  1. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002; 288 : 321–33. [Google Scholar]
  2. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and estrogen/ progestin replacement study (HERS) research group. JAMA 1998; 280 : 605–13. [Google Scholar]
  3. Holm P. Effect of estrogen on development of atherosclerosis. A review of experimental animal studies. Dan Med Bull 2002; 48 : 146–60. [Google Scholar]
  4. Hodgin J, Maeda N. Estrogen and mouse models of atherosclerosis. Endocrinology 2002; 143 : 4495–501. [Google Scholar]
  5. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340 : 115–25. [Google Scholar]
  6. Elhage R, Arnal JF, Pierragi MT, et al. Estradiol-17b prevents fatty streak formation in apolipoprotein E-deficient mice. Arterioscl Thromb Vasc Biol 1997; 17 : 2679–84. [Google Scholar]
  7. Mendelsohn ME. Nongenomic, ER-mediated activation of endothelial nitric oxide synthase: how does it work ? What does it mean ? Circ Res 2000; 87 : 956–60. [Google Scholar]
  8. Couse JF, Korach KS. Estrogen receptor null mice : what have we learned and where will they lead us ? Endocrinol Rev 1999; 20 : 358–417. [Google Scholar]
  9. Makela S, Savolainen H, Aavik E, et al. Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors alpha and beta. Proc Natl Acad Sci USA 1999; 96 : 7077–82. [Google Scholar]
  10. Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, Smithies O. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci USA 1993; 90 : 11162–6. [Google Scholar]
  11. Dupont S, Krust A, Gansmuller A, Dierich A, Chambon P, Mark M. Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development 2000; 127 : 4277–91. [Google Scholar]
  12. Couse JF, Curtis SW, Washburn TF, et al. Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene. Mol Endocrinol 1995; 9 : 1441–54. [Google Scholar]
  13. Flouriot G, Brand H, Denger S, et al. Identification of a new isoform of the human estrogen receptor-alpha (hER-alpha) that is encoded by distinct transcripts and that is able to repress hER-alpha activation function 1. Embo J 2000; 19 : 4688–700. [Google Scholar]
  14. Pendaries C, Darblade B, Rochaix P, et al. The AF-1 activation-function of ERalpha may be dispensable to mediate the effect of estradiol on endothelial NO production in mice. Proc Natl Acad Sci USA 2002; 99 : 2205–10. [Google Scholar]
  15. Darblade B, Pendaries C, Krust A, et al. Estradiol alters nitric oxide production in the mouse aorta through the alpha-, but not beta-, estrogen receptor. Circ Res 2002; 90 : 413–9. [Google Scholar]
  16. Elhage R, Bayard F, Richard V, et al. The prevention of fatty streak formation of 17b-estradiol is not mediated by the production of nitric oxide in apolipoprotein E-deficient mice. Circulation 1997; 96 : 3048–52. [Google Scholar]
  17. Brouchet L, Krust A, Dupont S, Chambon P, Bayard F, Arnal JF. Estradiol accelerates reendothelialization in mouse carotid artery through a-, but not b-, estrogen receptor. Circulation 2001; 103 : 423–8. [Google Scholar]
  18. Spyridopoulos I, Sullivan AB, Kearney M, Isner JM, Losordo DW. Estrogen-receptor-mediated inhibition of human endothelial cell apoptosis. Estradiol as a survival factor. Circulation 1997; 95 : 1505–14. [Google Scholar]
  19. Gourdy P, Mallat Z, Castano C, et al. The atheroprotective effect of 17 -estradiol is not altered in P-selectin- or ICAM-1-deficient hypercholesterolemic mice. Atherosclerosis 2003; 166 : 41–8. [Google Scholar]
  20. Hodgin JB, Krege JH, Reddick RL, Korach KS, Smithies O, Maeda N. Estrogen receptor alpha is a major mediator of 17beta-estradiol’s atheroprotective effects on lesion size in Apoe−/− mice. J Clin Invest 2001; 107 : 333–40. [Google Scholar]
  21. Hodgin J, Maeda N. Estrogen and mouse models of atherosclerosis. Endocrinology 2002; 143 : 4495–501. [Google Scholar]
  22. Dansky H, Charlton S, McGee Harper M, Smith J. T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci USA 1997; 94 : 4642–6. [Google Scholar]
  23. Elhage R, Clamens S, Reardon-Alulis C, et al. Loss of the atheroprotective effect of estradiol in immunodeficient mice. Endocrinology 2000; 141 : 462–4. [Google Scholar]
  24. Chiba H, Chambon P, Metzger D. F9 embryonal carcinoma cells engineered for tamoxifen-dependent Cre-mediated site-directed mutagenesis and doxycycline-inducible gene expression. Exp Cell Res 2000; 260 : 334–9. [Google Scholar]
  25. Elhage R, Maret A, Pieraggi MT, Thiers JC, Arnal JF, Bayard F. Differential effects of interleukin-1 receptor antagonist and tumor necrosis factor binding protein on fatty-streak formation in apolipoprotein E-deficient mice. Circulation 1998; 97 : 242–4. [Google Scholar]
  26. Mallat Z, Besnard S, Duriez M, et al. Protective role of interleukin-10 in atherosclerosis. Circ Res 1999; 85 : E17–24. [Google Scholar]
  27. Elhage R, Clamens S, Besnard S, et al. Involvement of interleukin-6 in atherosclerosis but not in the prevention of fatty streak formation by 17beta-estradiol in apolipoprotein E-deficient mice. Atherosclerosis 2001; 156 : 315–20. [Google Scholar]
  28. Maret A, Coudert JD, Garidou L, et al. Estradiol enhances primary antigen-specific CD4 T cell responses and Th1 development in vivo. Essential role of estrogen receptor alpha expression in hematopoietic cells. Eur J Immunol 2003; 33 : 512–21. [Google Scholar]
  29. Libby P, Schoenbeck U, Mach F, Selwyn AP, Ganz P. Current concepts in cardiovascular pathology : the role of LDL cholesterol in plaque rupture and stabilization. Am J Med 1998; 104 : S14–8. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.